Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 7Lung Neoplasms 3Sarcoma, Ewing 2Desmoplastic Small Round Cell Tumor 2Sarcoma 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pegylated granulocyte colony-stimulating factor 2trilaciclib 1plerixafor 1eravacycline 1ceftolozane, tazobactam drug combination 1Piperacillin, Tazobactam Drug Combination 1PM 01183 1Loratadine 1Blood Specimen Collection 1Antiviral Agents 1Antifungal Agents 1Anti-Infective Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neutropenia × PM 01183 × Clear all
NCT05578326 2026-03-30

Study of Trilaciclib and Lurbinectidin

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
30 enrolled
Thoracic

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡